MannKind 概述 2026 年 Furoscix 營收目標為 1.1 億至 1.2 億美元，ReadyFlow 將於數週內出貨 ($MNKD)
· seekingalpha.com
MannKind ($MNKD) 2026 年第二季財報電話會議回顧：Afrezza 兒科採用率、Furoscix ReadyFlow 上市時程、營收結構、現金狀況與風險——立即閱讀。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...